Sun et al. demonstrated that tetrahydrocurcumin targets TRIP13, inhibits TRIP13/USP7/c-FLIP interaction, and mediates c-FLIP ubiquitination in triple-negative breast cancer [21]. The gene discussed is USP7; the disease is triple-negative breast carcinoma.